Pres & CEO: John McManus of Aeolus Pharmaceuticals (OTC:AOLS)

.
.
.

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development a platform of novel compounds in oncology and biodefense. The company develops a class of catalytic antioxidant compounds as a medical countermeasure against biological, chemical, and radiological weapons, as well as for diseases and disorders of the central nervous system, respiratory system, autoimmune system, and oncology. Its lead compound, AEOL 10150, which completed two Phase I clinical trials is developed against the pulmonary sub-syndrome of acute radiation syndrome, as well as the gastrointestinal sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure (MCM) for exposure to chemical vesicants such as chlorine gas, sulfur mustard gas, and nerve agents. The company also develops AEOL 11207 for treatment of epilepsy and Parkinsons disease and epilepsy; and AEOL 10171 as a potential MCM for acute radiation syndrome. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.

canadian pharmacy

0 Comments

You can be the first one to leave a comment.

Click here to cancel reply.

The Stock Radio ("TSR") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of TSR may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. TSR, the authors, the publisher, and all affiliates of TSR assume no responsibility or liability for your trading and investment results. Factual statements on the TSR's website, or in its publications, are made as of the date stated and are subject to change without notice. For TSR full disclaimer and disclosure go to our disclaimer page. It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by TSR are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of TSR's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on TSR's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Pres & CEO: John McManus of Aeolus Pharmaceuticals (OTC:AOLS)

0 Comments

Leave a Comment